Nifty
Sensex
:
:
25709.85
83952.19
124.55 (0.49%)
484.53 (0.58%)

Pharmaceuticals & Drugs

Rating :
41/99

BSE: 532637 | NSE: MANGALAM

70.19
17-Oct-2025
  • Open
  • High
  • Low
  • Previous Close
  •  70.28
  •  70.96
  •  69.8
  •  70.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  6709
  •  472343.25
  •  128.01
  •  68

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 111.40
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 197.05
  • N/A
  • 0.87

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.30%
  • 1.70%
  • 44.99%
  • FII
  • DII
  • Others
  • 0.11%
  • 0.00%
  • 2.90%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.76
  • -3.72
  • -5.09

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.47
  • -9.21
  • 6.84

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -8.06
  • -24.37
  • 75.97

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.72
  • 0.72
  • 0.72

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.37
  • 5.37
  • 5.37

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
57.35
76.54
-25.07%
73.04
102.24
-28.56%
88.71
97.34
-8.87%
79.94
0.00
0
Expenses
61.83
68.33
-9.51%
62.88
90.54
-30.55%
79.94
90.36
-11.53%
71.24
0.00
0
EBITDA
-4.48
8.21
-
10.16
11.70
-13.16%
8.77
6.98
25.64%
8.70
0.00
0
EBIDTM
-7.81%
10.72%
13.91%
11.44%
9.88%
7.17%
10.89%
0.00%
Other Income
0.00
0.02
-100.00%
0.21
0.05
320.00%
0.14
0.00
0
0.14
0.00
0
Interest
4.04
3.76
7.45%
4.03
3.95
2.03%
3.49
3.31
5.44%
3.67
0.00
0
Depreciation
4.48
3.88
15.46%
4.70
3.86
21.76%
4.05
3.63
11.57%
3.98
0.00
0
PBT
-13.00
0.59
-
1.63
3.93
-58.52%
1.37
0.04
3,325.00%
1.20
0.00
0
Tax
0.80
-2.10
-
1.57
0.40
292.50%
0.08
-0.46
-
-1.49
0.00
-
PAT
-13.80
2.69
-
0.06
3.53
-98.30%
1.29
0.50
158.00%
2.69
0.00
0
PATM
-24.06%
3.51%
0.08%
3.45%
1.45%
0.51%
3.36%
0.00%
EPS
-8.72
1.70
-
0.04
2.23
-98.21%
0.81
0.31
161.29%
1.70
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Net Sales
-
318.23
368.59
Net Sales Growth
-
-13.66%
 
Cost Of Goods Sold
-
167.37
244.51
Gross Profit
-
150.86
124.08
GP Margin
-
47.41%
33.66%
Total Expenditure
-
282.41
351.22
Power & Fuel Cost
-
27.89
28.50
% Of Sales
-
8.76%
7.73%
Employee Cost
-
40.59
39.07
% Of Sales
-
12.75%
10.60%
Manufacturing Exp.
-
27.37
21.80
% Of Sales
-
8.60%
5.91%
General & Admin Exp.
-
5.17
6.15
% Of Sales
-
1.62%
1.67%
Selling & Distn. Exp.
-
8.93
6.93
% Of Sales
-
2.81%
1.88%
Miscellaneous Exp.
-
5.10
4.24
% Of Sales
-
1.60%
1.15%
EBITDA
-
35.82
17.37
EBITDA Margin
-
11.26%
4.71%
Other Income
-
0.50
0.12
Interest
-
14.93
13.92
Depreciation
-
16.61
14.65
PBT
-
4.79
-11.07
Tax
-
-1.93
-2.00
Tax Rate
-
-40.29%
18.07%
PAT
-
6.72
-9.07
PAT before Minority Interest
-
6.72
-9.07
Minority Interest
-
0.00
0.00
PAT Margin
-
2.11%
-2.46%
PAT Growth
-
-
 
EPS
-
4.25
-5.74

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Shareholder's Funds
148.98
135.79
Share Capital
15.83
15.83
Total Reserves
133.15
119.96
Non-Current Liabilities
25.84
33.85
Secured Loans
8.70
12.44
Unsecured Loans
0.53
0.91
Long Term Provisions
0.00
0.00
Current Liabilities
191.60
164.06
Trade Payables
91.15
66.16
Other Current Liabilities
26.49
22.31
Short Term Borrowings
71.94
74.60
Short Term Provisions
2.02
0.99
Total Liabilities
366.42
333.70
Net Block
162.73
147.67
Gross Block
288.26
261.27
Accumulated Depreciation
125.53
113.60
Non Current Assets
167.44
157.70
Capital Work in Progress
2.69
7.74
Non Current Investment
0.00
0.00
Long Term Loans & Adv.
2.01
2.29
Other Non Current Assets
0.00
0.00
Current Assets
198.98
176.00
Current Investments
0.00
0.00
Inventories
138.80
123.64
Sundry Debtors
39.07
27.94
Cash & Bank
2.59
1.19
Other Current Assets
18.52
1.69
Short Term Loans & Adv.
16.88
21.54
Net Current Assets
7.38
11.94
Total Assets
366.42
333.70

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Cash From Operating Activity
42.59
3.91
PBT
4.79
3.97
Adjustment
30.60
13.95
Changes in Working Capital
7.29
-13.91
Cash after chg. in Working capital
42.68
4.00
Interest Paid
0.00
0.00
Tax Paid
-0.08
-0.09
Other Direct Exp. Paid
0.00
0.00
Extra & Other Items
0.00
0.00
Cash From Investing Activity
-19.47
-11.83
Net Fixed Assets
-14.40
Net Investments
0.00
Others
-5.07
Cash from Financing Activity
-21.71
5.23
Net Cash Inflow / Outflow
1.41
-2.69
Opening Cash & Equivalents
1.18
3.87
Closing Cash & Equivalent
2.59
1.18

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Book Value (Rs.)
89.65
85.79
ROA
1.92%
-2.72%
ROE
4.84%
-6.68%
ROCE
8.55%
1.23%
Fixed Asset Turnover
1.16
1.41
Receivable days
38.43
27.67
Inventory Days
150.51
122.43
Payable days
171.53
98.76
Cash Conversion Cycle
17.41
51.34
Total Debt/Equity
0.62
0.70
Interest Cover
1.32
0.20

News Update:


  • Mangalam Drugs and Organics gets order from international client
    22nd Aug 2025, 15:12 PM

    The aggregate value of the order under the said purchase order is $21,81,040

    Read More
  • Mangalam Drugs&Org. - Quarterly Results
    7th Aug 2025, 20:50 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.